Skip to content
Explore cutting-edge technology insights, AI trends, and di…

Users Coming Off Slimming Medications Gain Back Pounds at a Quadrupled Rate Compared to Dieters

Illustration of pharmaceutical syringe and weighing machine
Obesity treatment involves ongoing approaches.

New research reveals that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt conventional diet and exercise regimens.

Research printed in a major medical journal points out that while obese people frequently drop a large proportion of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit.

"People purchasing these drugs need to be cognizant of the danger of rapid weight regain when the medication ends," stated researcher Dr. Susan Jebb.

This pace of regain implies a reversion to starting mass in about a year and a half.

Comparing Approaches

The study, which reviewed dozens of trials involving over 9,000 of patients, compared the effects of these new drugs with older methods.

The team note that individuals who lose weight through diet and exercise typically have a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.

Understanding the Fast Regain

Experts suggest the mode of action of the jabs accounts for the amplified regain.

These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Sustained high doses of GLP-1 levels several times higher than normal might result in the body to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this GLP-1 'fix' leads to appetite is no longer kept in check, making binge eating much more probable."

A Chronic Condition?

The NHS recommend the jabs for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

Many experts contend that, considering the significant potential of weight regain, the treatment might need to be ongoing.

This opinion is supported by pharmaceutical companies, who state that the findings "emphasize the chronic nature of obesity," comparing it to managing diseases like hypertension.

User Testimonies

Users who have stopped the jabs explain a sudden resurgence of cravings.

"It felt as if a trigger flipping and you become extremely hungry," said an individual.

This difficulty is worsened if users have not developed sustainable lifestyle or habit modifications during therapy.

Significant Use

Survey data suggest that millions of people in the UK have used these injections in the past year, with interest remaining high.

  • Use is more common among women compared to men.
  • The middle-aged age group shows the highest usage rates.
  • Many obtain the drugs through private healthcare rather than the NHS.

Ultimately, clinicians stress that while the jabs are potent tools for weight loss, they are not a magic fix and lasting health benefits hinges on combined lifestyle management.

The writer

Julie Allen

A data scientist and tech writer passionate about demystifying AI and emerging technologies through accessible, actionable content.

VertexLucky

Type to search articles.